Perinatal Cells: A Promising COVID-19 Therapy?

PLacental eXpanded coronavirus-induced disease 2019 mesenchymal stromal cells perinatal severe acute respiratory distress syndrome coronavirus-2

Journal

Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513

Informations de publication

Date de publication:
2020
Historique:
received: 21 10 2020
accepted: 08 12 2020
entrez: 1 2 2021
pubmed: 2 2 2021
medline: 2 2 2021
Statut: epublish

Résumé

The COVID-19 pandemic has become a priority in the health systems of all nations worldwide. In fact, there are currently no specific drugs or preventive treatments such as vaccines. The numerous therapies available today aim to counteract the symptoms caused by the viral infection that in some subjects can evolve causing acute respiratory distress syndromes (ARDS) with consequent admission to intensive care unit. The exacerbated response of the immune system, through cytokine storm, causes extensive damage to the lung tissue, with the formation of edema, fibrotic tissues and susceptibility to opportunistic infections. The inflammatory picture is also aggravated by disseminated intravascular coagulation which worsens the damage not only to the respiratory system, but also to other organs. In this context, perinatal cells represent a valid strategy thanks to their strong immunomodulatory potential, their safety profile, the ability to reduce fibrosis and stimulate reparative processes. Furthermore, perinatal cells exert antibacterial and antiviral actions. This review therefore provides an overview of the characteristics of perinatal cells with a particular focus on the beneficial effects that they could have in patients with COVID-19, and more specifically for their potential use in the treatment of ARDS and sepsis.

Identifiants

pubmed: 33520970
doi: 10.3389/fbioe.2020.619980
pmc: PMC7841388
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

619980

Informations de copyright

Copyright © 2021 Papait, Cargnoni, Sheleg, Silini, Kunis, Ofir and Parolini.

Déclaration de conflit d'intérêts

MS, GK, and RO are employed by the company Pluristem Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Stem Cells Transl Med. 2015 May;4(5):448-58
pubmed: 25824141
Exp Hematol. 2005 Aug;33(8):928-34
pubmed: 16038786
Lancet. 2020 May 2;395(10234):e75
pubmed: 32330428
Cell Stem Cell. 2008 Feb 7;2(2):141-50
pubmed: 18371435
Arthritis Rheumatol. 2014 Feb;66(2):327-39
pubmed: 24504805
Blood. 2011 May 5;117(18):4826-35
pubmed: 21389316
Gut. 2009 Jul;58(7):929-39
pubmed: 19136511
Trends Mol Med. 2019 Feb;25(2):149-163
pubmed: 30711482
Stem Cell Res Ther. 2018 Jan 29;9(1):17
pubmed: 29378639
Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3621-6
pubmed: 26976597
Lancet. 2020 May 9;395(10235):1517-1520
pubmed: 32311318
Cell Transplant. 2012;21(7):1477-92
pubmed: 22507554
Stem Cells Transl Med. 2020 Jan;9(1):17-27
pubmed: 31804767
Autoimmun Rev. 2020 Jul;19(7):102568
pubmed: 32376398
Signal Transduct Target Ther. 2020 Aug 27;5(1):172
pubmed: 32855385
Stem Cells Int. 2019 Feb 5;2019:2457082
pubmed: 30867667
Cell Immunol. 2011;272(1):33-8
pubmed: 22004796
Stem Cells. 2013 Feb;31(2):397-407
pubmed: 23132816
Am J Respir Crit Care Med. 2010 Sep 1;182(5):643-51
pubmed: 20522792
Stem Cells Dev. 2011 Dec;20(12):2115-26
pubmed: 21381973
Stem Cells. 2006 Nov;24(11):2466-77
pubmed: 17071860
Stem Cells Transl Med. 2018 Feb;7(2):180-196
pubmed: 29297621
Stem Cell Rev Rep. 2013 Feb;9(1):16-31
pubmed: 22628114
PLoS One. 2016 Oct 3;11(10):e0163709
pubmed: 27695127
Front Immunol. 2020 Jun 09;11:1156
pubmed: 32582218
Stem Cell Res Ther. 2020 May 4;11(1):169
pubmed: 32366290
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Stem Cells. 2008 Jan;26(1):182-92
pubmed: 17901399
Stem Cells Dev. 2017 Jul 15;26(14):1054-1064
pubmed: 28401804
J Tissue Eng Regen Med. 2017 Oct;11(10):2895-2911
pubmed: 27396853
Shock. 2014 Feb;41(2):123-9
pubmed: 24169208
Blood. 2003 May 1;101(9):3722-9
pubmed: 12506037
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
PLoS One. 2018 Jun 1;13(6):e0196048
pubmed: 29856737
Lancet Respir Med. 2020 Aug;8(8):807-815
pubmed: 32422178
Int J Hematol. 2004 Feb;79(2):103-8
pubmed: 15005335
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Cytotherapy. 2018 Feb;20(2):232-244
pubmed: 29167063
Stem Cell Res Ther. 2016 Oct 28;7(1):159
pubmed: 27793190
Clin Exp Immunol. 2012 Mar;167(3):543-55
pubmed: 22288598
Transplantation. 2004 Nov 27;78(10):1439-48
pubmed: 15599307
Nat Commun. 2020 Jul 6;11(1):3434
pubmed: 32632085
Sci Rep. 2018 Jan 12;8(1):670
pubmed: 29330447
Stem Cells. 2004;22(7):1338-45
pubmed: 15579651
JAMA. 2020 Apr 28;323(16):1612-1614
pubmed: 32191259
Stem Cells Transl Med. 2017 Apr;6(4):1085-1095
pubmed: 28371562
Am J Respir Crit Care Med. 2018 Jan 1;197(1):104-116
pubmed: 28853608
World J Stem Cells. 2015 Mar 26;7(2):368-79
pubmed: 25815121
Am J Respir Crit Care Med. 2010 Oct 15;182(8):1047-57
pubmed: 20558630
Lancet Respir Med. 2020 Aug;8(8):750-752
pubmed: 32422177
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Crit Care Explor. 2020 Sep 15;2(9):e0207
pubmed: 32984833
Stem Cell Res Ther. 2019 Aug 1;10(1):231
pubmed: 31370884
Biomed Res Int. 2015;2015:317801
pubmed: 25984529
Tissue Eng Part A. 2010 Nov;16(11):3537-46
pubmed: 20597819
Clin Sci (Lond). 2016 Apr 1;130(7):513-23
pubmed: 26685104
Blood. 2008 Aug 1;112(3):532-41
pubmed: 18445691
Adv Pharm Bull. 2020 Jan;10(1):72-80
pubmed: 32002364
PLoS One. 2012;7(10):e46956
pubmed: 23071674
Cytotherapy. 2014 Jan;16(1):17-32
pubmed: 24094500
Stem Cells. 2008 Nov;26(11):2865-74
pubmed: 18703664
Stem Cells. 2010 Dec;28(12):2229-38
pubmed: 20945332
Int J Med Sci. 2013;10(1):8-18
pubmed: 23289000
Life Sci. 2020 Feb 15;243:117290
pubmed: 31923420
PLoS One. 2013;8(4):e59348
pubmed: 23565148
Nat Immunol. 2020 Sep;21(9):974-982
pubmed: 32747813
Blood. 2020 Jun 4;135(23):2033-2040
pubmed: 32339221
Lancet Rheumatol. 2020 Aug;2(8):e474-e484
pubmed: 32835257
J Inflamm (Lond). 2005 Jul 26;2:8
pubmed: 16045800
Bioinformation. 2020 Mar 31;16(3):219-222
pubmed: 32308263
Cell Immunol. 2015 Feb;293(2):59-66
pubmed: 25569483
Am J Physiol Lung Cell Mol Physiol. 2007 Jul;293(1):L131-41
pubmed: 17416739
Cell Res. 2008 Aug;18(8):846-57
pubmed: 18607390
Lancet Respir Med. 2015 Jan;3(1):24-32
pubmed: 25529339
Anesthesiology. 2019 May;130(5):778-790
pubmed: 30870158
Gut. 2013 Aug;62(8):1131-41
pubmed: 22637701
Int J Mol Med. 2014 Feb;33(2):263-70
pubmed: 24297321
PLoS One. 2013 Aug 01;8(8):e69299
pubmed: 23936322
Cell Transplant. 2009;18(4):405-22
pubmed: 19622228
Mol Immunol. 2017 Oct;90:11-21
pubmed: 28662409
Cell Immunol. 2010;264(2):171-9
pubmed: 20619400
Cell Microbiol. 2016 Mar;18(3):424-36
pubmed: 26350435
J Vet Sci. 2012 Mar;13(1):23-31
pubmed: 22437532
Stem Cells Transl Med. 2017 Dec;6(12):2135-2145
pubmed: 29024485
Cell Transplant. 2009;18(8):899-914
pubmed: 19523334
Cytotherapy. 2020 Sep;22(9):482-485
pubmed: 32425691
N Engl J Med. 2020 Dec 10;383(24):2333-2344
pubmed: 33085857
Am J Physiol Lung Cell Mol Physiol. 2014 Sep 1;307(5):L395-406
pubmed: 25038188
Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jul 22;32(2):106-14
pubmed: 26278689
Nat Biotechnol. 2007 Jan;25(1):100-6
pubmed: 17206138
Signal Transduct Target Ther. 2020 Mar 27;5(1):33
pubmed: 32296069
Stem Cell Rev Rep. 2015 Jun;11(3):394-407
pubmed: 25348066
Stem Cell Res Ther. 2015 Jan 29;6:8
pubmed: 25634246
J Cell Mol Med. 2016 Jan;20(1):157-69
pubmed: 26515425
Stem Cells. 2008 Feb;26(2):300-11
pubmed: 17975221
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
Respirology. 2014 Oct;19(7):1013-8
pubmed: 25039426
J Cell Mol Med. 2019 Feb;23(2):1581-1592
pubmed: 30585395
Front Immunol. 2017 Mar 30;8:339
pubmed: 28424688
Lancet Rheumatol. 2020 Jul;2(7):e393-e400
pubmed: 32835245
Future Sci OA. 2018 Oct 26;4(10):FSO351
pubmed: 30450234
PLoS One. 2013 Aug 15;8(8):e71761
pubmed: 23967240
Nat Rev Nephrol. 2018 Aug;14(8):493-507
pubmed: 29895977
Cell Immunol. 2011;270(2):207-16
pubmed: 21700275
J Infect Dis. 2019 Jan 7;219(2):186-196
pubmed: 30085072
J Surg Res. 2013 Nov;185(1):70-83
pubmed: 23830369
PLoS One. 2010 Feb 02;5(2):e9016
pubmed: 20126406
Eur Respir J. 2020 Jun 4;55(6):
pubmed: 32265310
Tissue Eng. 2007 Jun;13(6):1173-83
pubmed: 17518752
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Stem Cells. 2004;22(7):1330-7
pubmed: 15579650
Cryobiology. 2015 Oct;71(2):181-97
pubmed: 26186998
Stem Cell Res Ther. 2020 Mar 4;11(1):99
pubmed: 32131892
Immunol Cell Biol. 2010 Nov-Dec;88(8):795-806
pubmed: 20386557
Cell Transplant. 2011;20(6):909-23
pubmed: 21092408
Surgery. 2010 Aug;148(2):444-52
pubmed: 20434747
Stem Cells. 2014 Feb;32(2):521-33
pubmed: 24105952
Lancet Respir Med. 2020 Jun;8(6):e46-e47
pubmed: 32353251
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
Stem Cells. 2006 Feb;24(2):386-98
pubmed: 16123384
Stem Cells Transl Med. 2019 May;8(5):456-465
pubmed: 30720934
Cells. 2020 Jan 06;9(1):
pubmed: 31935836
Dev Comp Immunol. 2010 Apr;34(4):474-9
pubmed: 20026347
Am J Pathol. 2009 Jul;175(1):303-13
pubmed: 19497992
Stem Cells Transl Med. 2020 Sep;9(9):1023-1035
pubmed: 32452646
Nat Med. 2009 Jan;15(1):42-9
pubmed: 19098906
Crit Care. 2020 Jul 11;24(1):420
pubmed: 32653043
Transl Res. 2020 Jun;220:1-13
pubmed: 32299776
Trends Immunol. 2012 Mar;33(3):136-43
pubmed: 22227317
Stem Cell Res Ther. 2020 Aug 18;11(1):361
pubmed: 32811531
Hum Immunol. 2008 Jun;69(6):321-8
pubmed: 18571002
Cytotherapy. 2012 Feb;14(2):153-61
pubmed: 21954836
Am J Hematol. 2020 Jul;95(7):876-878
pubmed: 32282956
Exp Ther Med. 2017 May;13(5):1922-1926
pubmed: 28565787
EBioMedicine. 2020 May;55:102763
pubmed: 32361250
J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):880-897
pubmed: 30230266
J Thromb Haemost. 2020 May;18(5):1233-1234
pubmed: 32291954
Cell Transplant. 2013;22(8):1337-49
pubmed: 23044339
Eur J Vasc Endovasc Surg. 2019 Apr;57(4):538-545
pubmed: 30686676
Am J Respir Crit Care Med. 2018 Feb 1;197(3):337-347
pubmed: 28960096
Stem Cells. 2014 Jul;32(7):1865-77
pubmed: 24496748
Cytotherapy. 2019 Jan;21(1):41-53
pubmed: 30477894
Eur Radiol. 2020 Jun;30(6):3306-3309
pubmed: 32055945
N Engl J Med. 2020 Apr 23;382(17):e38
pubmed: 32268022
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Radiology. 2020 Aug;296(2):E55-E64
pubmed: 32191587
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
J Infect. 2020 Jun;80(6):e14-e18
pubmed: 32171866
Thorax. 2012 Jun;67(6):533-9
pubmed: 22250097
Geroscience. 2020 Apr;42(2):505-514
pubmed: 32274617
N Engl J Med. 2020 May 21;382(21):2012-2022
pubmed: 32227758
Am J Physiol Regul Integr Comp Physiol. 2011 Jun;300(6):R1506-14
pubmed: 21451141
Stem Cell Res Ther. 2020 Mar 13;11(1):116
pubmed: 32169108
PLoS One. 2011;6(9):e25171
pubmed: 21980392
Int J Mol Med. 2014 Sep;34(3):695-704
pubmed: 24970492
Front Immunol. 2019 Jul 31;10:1645
pubmed: 31417542
Front Bioeng Biotechnol. 2015 Oct 19;3:162
pubmed: 26539433
Lancet Haematol. 2020 May;7(5):e362-e363
pubmed: 32278361
Theranostics. 2019 Sep 17;9(22):6646-6664
pubmed: 31588241
N Engl J Med. 2020 May 14;382(20):e60
pubmed: 32343504
Oncotarget. 2017 Jul 11;8(28):45626-45642
pubmed: 28484089
Front Bioeng Biotechnol. 2020 Dec 17;8:610544
pubmed: 33392174

Auteurs

Andrea Papait (A)

Department of Life Science and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
Centro di Ricerca E. Menni, Fondazione Poliambulanza-Istituto Ospedaliero, Brescia, Italy.

Anna Cargnoni (A)

Centro di Ricerca E. Menni, Fondazione Poliambulanza-Istituto Ospedaliero, Brescia, Italy.

Michal Sheleg (M)

Pluristem Ltd., Haifa, Israel.

Antonietta R Silini (AR)

Centro di Ricerca E. Menni, Fondazione Poliambulanza-Istituto Ospedaliero, Brescia, Italy.

Gilad Kunis (G)

Pluristem Ltd., Haifa, Israel.

Racheli Ofir (R)

Pluristem Ltd., Haifa, Israel.

Ornella Parolini (O)

Department of Life Science and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Rome, Italy.

Classifications MeSH